This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Biotechnology: The underutilised tool in the fight for global health and security
Go to paperABSTRACT: Biotechnology companies can contribute to developi…
Biotechnology: The underutilised tool in the fight for global health and security Read Post »
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Beacon Sciences: Commercialisation from biothreat detection to beauty enhancement
Go to paperABSTRACT: Beacon Sciences is an excellent example of how te…
Beacon Sciences: Commercialisation from biothreat detection to beauty enhancement Read Post »
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s
Natural Products – Part 3: Ensuring Patentability for Novel Diagnostics and Therapies Read Post »
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Legal and regulatory update
Go to paperABSTRACT: Article 81(1) of the Treaty of Rome prohibits all agreements, decisions and concerted practices that ma…
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Growth of Indian biotech companies, in the context of the international biotechnology industry
Go to paperABSTRACT: The paper discusses the evolution and…
TechTransferWatch is a search engine and alert service for licenseable technologies from academic labs, foundations, and government. Click the patents
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Patent issues and future trends in drug development
Go to paperABSTRACT: The global biopharmaceutical industry has been one of the most productive and p…
Patent issues and future trends in drug development Read Post »
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s
Natural Products – Part 2: From the Biomes to the Microbiome Read Post »
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s
Natural Products: A New Golden Age in Drug Development? Read Post »
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
ApaTech: A biomaterials success story
Go to paperABSTRACT: ApaTech is an excellent example of how innovative technology from a British university can be…